Of note, similar trends were observed in two BC models, when SRC-3 was directly inhibited in tumor cells (shRNA) prior to inoculation; tumor growth was successfully suppressed by SI-2 treatment in a wild type (WT), but not immunodeficient mice. The gene discussed is NCOA3; the disease is breast cancer.